Herbal compounds that inhibit TNF-α and TGF-β may offer therapeutic benefits in AIH by reducing immune-mediated inflammation and subsequent fibrosis. The dual inhibition of these pathways could potentially slow the progression of fibrosis and improve liver function in patients with AIH [42, 43]. The gene discussed is TGFB1; the disease is autoimmune hepatitis.